Endo ERN
Find an expert
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

890 publication(s) found matching the search criteria

ESE audit on management of adult growth hormone deficiency in clinical practice


Author(s): Martel-Duguech L, Jorgensen JOL, Korbonits M, Johannsson G, Webb SM, _ _, _ _, Adamidou F, Mintziori G, Arosio M, Giavoli C, Badiu C, Boschetti M, Ferone D, Ricci Bitti S, Brue T, Albarel F, Cannavo S, Martino G, Cotta OR, Carvalho D, Salazar D, Christ E, Debono M, Dusek T, García R, Ghigo E, Gasco V, Goth MI, Olah D, Kovacs L, Höybye C, Kocjan T, Mlekuš Kozamernik K, Kužma M, Medic Stojanoska M, Novak A, Miličević T, Pekic S, Milijic D, Perez Luis J, Pico A, Preda V, Raverot G, Borson-Chazot F, Rochira V, Monzani ML, Sandahl K, Tsagarakis S, Mitravela V, Zacharieva S, Zilatiene B, Verkauskiene R
Affiliated Institution / ERN:
Condition / Disease: Growth Hormone Deficiency
Publication: European Journal of Endocrinology v184.2 p321-332 Year: 2021 ORPHAcode / other: ORPHA101957
DOI: 10.1530/EJE-20-1180 Keywords:
MTG6

Puberty and fertility in classic galactosemia


Author(s): Flechtner I, Viaud M, Kariyawasam D, Perrissin-Fabert M, Bidet M, Bachelot A, Touraine P, Labrune P, de Lonlay P, Polak M
Affiliated Institution / ERN: Hospital Universitario Cruces ; ERN BOND ;
Condition / Disease: Galactosemia
Publication: Endocrine Connections v10.2 p240-247 Year: 2021 ORPHAcode / other: ORPHA352
DOI: 10.1530/EC-21-0013 Keywords: fertility,galactosemia,premature ovarian insufficiency,puberty

Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients


Author(s): Grani G, Zatelli MC, Alfò M, Montesano T, Torlontano M, Morelli S, Deandrea M, Antonelli A, Francese C, Ceresini G, Orlandi F, Maniglia CA, Bruno R, Monti S, Santaguida MG, Repaci A, Tallini G, Fugazzola L, Monzani F, Giubbini R, Rossetto R, Mian C, Crescenzi A, Tumino D, Pagano L, Pezzullo L, Lombardi CP, Arvat E, Petrone L, Castagna MG, Spiazzi G, Salvatore D, Meringolo D, Solaroli E, Monari F, Magri F, Triggiani V, Castello R, Piazza C, Rossi R, Ferraro Petrillo U, Filetti S, Durante C
Affiliated Institution / ERN: AOU Policlinico Umberto I - Rome ; AOU - Ferrara ; AO City of Health and Science - Turin ; AOU Pisan ; AOU-Bologna ; AOU Federico II - Naples ; AOUI Verona ; IRCCS Auxologico Italian Institute - Milan ;
Condition / Disease: Follicular thyroid carcinoma
Publication: Thyroid v31.2 p264-271 Year: 2021 ORPHAcode / other: ORPHA146
DOI: 10.1089/thy.2020.0272 Keywords: clinical practice,differentiated thyroid cancer,evidence-based guidelines,risk stratification
MTG8

Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndrome


Author(s): Geer EB, Salvatori R, Elenkova A, Fleseriu M, Pivonello R, Witek P, Feelders RA, Bex M, Borresen SW, Puglisi S, Biller BMK, Cohen F, Pecori Giraldi F
Affiliated Institution / ERN: AOU Federico II - Naples ; Evangelismos General Hospital ;
Condition / Disease: Cushing’s Syndrome
Publication: Pituitary v24.1 p104-115 Year: 2021 ORPHAcode / other: ORPHA553
DOI: 10.1007/s11102-020-01103-6 Keywords: Cushing’s disease,Cushing’s syndrome,Hypercortisolism,Quality of life,Steroidogenesis inhibitor
MTG1 MTG6

Socioeconomic status in patients with Turner syndrome


Author(s): Noordman ID, van der Velden JA, Timmers HJ, Reisch N, Richter-Unruh A, Pienkowksi C, Roeleveld N, Claahsen-van der Grinten HL
Affiliated Institution / ERN: Radboud University Medical Centre Nijmegen ; Klinikum der Universität München ; Katholisches Klinikum Bochum ; CHU de Toulouse ;
Condition / Disease: 45,X
Publication: Comprehensive Psychoneuroendocrinology v5 p100030 Year: 2021 ORPHAcode / other: ORPHA881
DOI: 10.1016/j.cpnec.2021.100030 Keywords: Karyotype,Socioeconomic status,Turner syndrome
MTG7

Relative Adipose Tissue Failure in Alström Syndrome Drives Obesity-Induced Insulin Resistance


Author(s): Geberhiwot T, Baig S, Obringer C, Girard D, Dawson C, Manolopoulos K, Messaddeq N, Bel Lassen P, Clement K, Tomlinson JW, Steeds RP, Dollfus H, Petrovsky N, Marion V
Affiliated Institution / ERN:
Condition / Disease: Alström syndrome
Publication: Diabetes v70.2 p364-376 Year: 2021 ORPHAcode / other: ORPHA64
DOI: 10.2337/db20-0647 Keywords: adipocyte-driven IR; obesity; AT-targeted; therapeutic strategies;diabetes;
MTG5

Assessing the health-related management of people with differences of sex development


Author(s): Jürgensen M, Rapp M, Döhnert U, Frielitz F, Ahmed F, Cools M, Thyen U, Hiort O
Affiliated Institution / ERN:
Condition / Disease:
Publication: Endocrine 2021(2) Year: 2021 ORPHAcode / other:
DOI: Keywords:
MTG7

Clinical management of patients with genetic obesity during COVID-19 pandemic: position paper of the ESE Growth & Genetic Obesity COVID-19 Study Group and Rare Endo-ERN main thematic group on Growth and Obesity


Author(s): De Groot CJ, Poitou Bernert C, Coupaye M, Clement K, Paschou SA, Charmandari E, Kanaka-Gantenbein C, Wabitsch M, Buddingh EP, Nieuwenhuijsen B, Marina L, Johannsson G, Van Den Akker ELT
Affiliated Institution / ERN:
Condition / Disease: Genetic Obesity
Publication: Endocrine 2021(2) Year: 2021 ORPHAcode / other: ORPHA77828
DOI: 10.1007/s12020-021-02619-y Keywords: COVID-19; Genetic obesity; Monogenic obesity; Obesity syndrome; SARS-CoV-2;
MTG5

Endo-ERN expert opinion on the differential diagnosis of pubertal delay


Author(s): Persani L, Bonomi M, Cools M, Dattani M, Dunkel L, Gravholt CH, Juul A
Affiliated Institution / ERN:
Condition / Disease: Congenital hypogonadotropic hypogonadism; Rare disorder with hypergonadotropic hypogonadism;
Publication: Endocrine 2021(2) Year: 2021 ORPHAcode / other: ORPHA174590; ORPHA181441;
DOI: 10.1007/s12020-021-02626-z Keywords: Constitutional delay of growth and puberty; Gonadal dysgenesis; Hypogonadism; Primary ovarian insufficiency; Pubertal delay; Sex steroid priming;
MTG7

Supporting international networks through platforms for standardised data collection—the European Registries for Rare Endocrine Conditions (EuRRECa) model


Author(s): Ali SR, Bryce J, Smythe C, Hytiris M, Priego AL, Appelman-Dijkstra NM, Ahmed SF
Affiliated Institution / ERN:
Condition / Disease:
Publication: Endocrine 2021(2) Year: 2021 ORPHAcode / other:
DOI: Keywords:

Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues


Author(s): Gallo M, Campione S, Di Vito V, Fortunati N, Lo Calzo F, Messina E, Ruggeri RM, Faggiano A, Colao AAL
Affiliated Institution / ERN: AO City of Health and Science - Turin ; AOU Federico II - Naples ; AOU polyclinic "G.Martino" of Messina ;
Condition / Disease: Neuroendocrine Neoplasm
Publication: Frontiers in Endocrinology v11 Year: 2021 ORPHAcode / other: ORPHA877
DOI: 10.3389/fendo.2020.610230 Keywords: breast cancer,breast carcinoma,breast neuroendocrine neoplasms,neuroendocrine,review

The Management of Neuroendocrine Tumors of the Lung in MEN1: Results From the Dutch MEN1 Study Group


Author(s): van den Broek MFM, de Laat JM, van Leeuwaarde RS, van de Ven AC, de Herder WW, Dekkers OM, Drent ML, Kerstens MN, Bisschop PH, Havekes B, Hackeng WM, Brosens LAA, Vriens MR, Buikhuisen WA, Valk GD
Affiliated Institution / ERN: University Medical Center Utrecht ; Radboud University Medical Centre Nijmegen ; Leiden University Medical Center ; Amsterdam UMC ; Erasmus MC: University Medical Center Rotterdam ; Maastricht University Medical Center+ ;
Condition / Disease: Multiple endocrine neoplasia type 1
Publication: The Journal of Clinical Endocrinology & Metabolism v106.2 pe1014-e1027 Year: 2021 ORPHAcode / other: ORPHA652
DOI: 10.1210/clinem/dgaa800 Keywords: lung NET,multiple endocrine neoplasia type 1,surveillance,survival,tumor growth
MTG4

Serum insulin-like factor 3 quantification by LC–MS/MS in male patients with hypogonadotropic hypogonadism and Klinefelter syndrome


Author(s): Johannsen TH, Ljubicic ML, Young J, Trabado S, Petersen JH, Linneberg A, Albrethsen J, Juul A
Affiliated Institution / ERN:
Condition / Disease:
Publication: Endocrine 2021(2) Year: 2021 ORPHAcode / other:
DOI: 10.1007/s12020-021-02609-0 Keywords:
MTG7

Multidisciplinary Approach to the Child with Sex Chromosomal Mosaicism Including a Y-Containing Cell Line


Author(s): Debo B, Van Loocke M, De Groote K, De Leenheer E, Cools M
Affiliated Institution / ERN: Ghent University Hospital ;
Condition / Disease: Other
Publication: International Journal of Environmental Research and Public Health v18.3 p917 Year: 2021 ORPHAcode / other: ORPHA325546
DOI: 10.3390/ijerph18030917 Keywords: 45,X/46,XY mosaicism,Turner syndrome,germ cell cancer,growth hormone,sex chromosomal mosaicism
MTG7

Introduction to Endo-ERN–scope and mission


Author(s): Pereira AM, Hiort O
Affiliated Institution / ERN:
Condition / Disease: Endo-ERN
Publication: Endocrine 2021(2) Year: 2021 ORPHAcode / other: ORPHA97978
DOI: 10.1007/s12020-020-02602-z Keywords: Endo-ERN; scope; raising awareness; reference networks;
MTG1 MTG2 MTG3 MTG4 MTG5 MTG6 MTG7 MTG8

An Innovative Approach to Designing Digital Health Solutions Addressing the Unmet Needs of Obese Patients in Europe


Author(s): Patalano R, De Luca V, Vogt J, Birov S, Giovannelli L, Carruba G, Pivonello C, Stroetmann V, Triassi M, Colao A, Illario M
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: Obesity
Publication: International Journal of Environmental Research and Public Health v18.2 p579 Year: 2021 ORPHAcode / other: 5B81.00
DOI: 10.3390/ijerph18020579 Keywords: Europe,digital health,healthy food,healthy life,nutrition,obese patients,obesity
MTG5

Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations


Author(s): Reincke M, Albani A, Assie G, Bancos I, Brue T, Buchfelder M, Chabre O, Ceccato F, Daniele A, Detomas M, Di Dalmazi G, Elenkova A, Findling J, Grossman AB, Gomez-Sanchez CE, Heaney AP, Honegger J, Karavitaki N, Lacroix A, Laws ER, Losa M, Murakami M, Newell-Price J, Pecori Giraldi F, Pérez‐Rivas LG, Pivonello R, Rainey WE, Sbiera S, Schopohl J, Stratakis CA, Theodoropoulou M, van Rossum EFC, Valassi E, Zacharieva S, Rubinstein G, Ritzel K
Affiliated Institution / ERN: Klinikum der Universität München ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ; Assistance Publique-Hôpitaux de Marseille ; University Hospital of Padova ; University Hospital Würzburg ; AOU-Bologna ; San Raffaele hospital - Milan ; IRCCS Auxologico Italian Institute - Milan ; AOU Federico II - Naples ; Erasmus MC: University Medical Center Rotterdam ; Hospital de la Santa Creu i Sant Pau ;
Condition / Disease: Cushing disease
Publication: European Journal of Endocrinology v184.3 pP1-P16 Year: 2021 ORPHAcode / other: ORPHA96253
DOI: 10.1530/EJE-20-1088 Keywords:
MTG6

Diazoxide-responsive hyperinsulinaemic hypoglycaemia in tyrosinaemia type 1


Author(s): Sotiridou E, Hoermann H, Aftab S, Dastamani A, Thimm E, Doodson L, Batzios S, Kummer S, Shah P
Affiliated Institution / ERN: Universitätsklinikum Düsseldorf ;
Condition / Disease: Diazoxide-sensitive diffuse hyperinsulinism
Publication: Endocrinology, Diabetes & Metabolism Case Reports v2021 Year: 2021 ORPHAcode / other: ORPHA165985
DOI: 10.1530/EDM-20-0174 Keywords:
MTG3

Molecular Differences Based on Erythrocyte Fatty Acid Profile to Personalize Dietary Strategies between Adults and Children with Obesity


Author(s): Jauregibeitia I, Portune K, Gaztambide S, Rica I, Tueros I, Velasco O, Grau G, Martín A, Castaño L, Larocca AV, Di Nolfo F, Ferreri C, Arranz S
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ; CHU de Toulouse ;
Condition / Disease: Obesity
Publication: Metabolites v11.1 p43 Year: 2021 ORPHAcode / other: 5B81.00
DOI: 10.3390/metabo11010043 Keywords: lipid metabolism,mature erythrocyte,obesity,precision nutrition
MTG5

Nutritional status and follicular-derived thyroid cancer: An update


Author(s): Barrea L, Gallo M, Ruggeri RM, Giacinto PD, Sesti F, Prinzi N, Adinolfi V, Barucca V, Renzelli V, Muscogiuri G, Colao A, Baldelli R
Affiliated Institution / ERN:
Condition / Disease: Follicular thyroid carcinoma
Publication: Critical Reviews in Food Science and Nutrition v61.1 p25-59 Year: 2021 ORPHAcode / other: ORPHA146
DOI: 10.1080/10408398.2020.1714542 Keywords: Follicular thyroid cancer,dietary factors,dietary pattern,nutritional factors,nutritionist,obesity
MTG8

GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice


Author(s): Biagetti B, Simó R
Affiliated Institution / ERN:
Condition / Disease: Acromegaly
Publication: International Journal of Molecular Sciences v22.1 p415 Year: 2021 ORPHAcode / other: ORPHA963
DOI: 10.3390/ijms22010415 Keywords: IGF-1,acromegaly,growth hormone,myopathy,review
MTG6

The opera prevention project


Author(s): Muscogiuri G, Barrea L, Laudisio D, Pugliese G, Aprano S, Framondi L, Di Matteo R, Riccio PA, Savastano S, Colao A
Affiliated Institution / ERN:
Condition / Disease: Obesity
Publication: International Journal of Food Sciences and Nutrition v72.1 p1-3 Year: 2021 ORPHAcode / other: 5B81.00
DOI: 10.1080/09637486.2020.1765152 Keywords: Obesity,lifestyle,nutrition,physical activity,prevention
MTG5

Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain


Author(s): Iglesias P, Nocete I, Moure Rodríguez MD, Venegas-Moreno E, Ares J, Biagetti B, Rodríguez Berrocal V, Guerrero-Pérez F, Vicente A, Villar-Taibo R, Cordido F, Paja M, Glerean M, González Rivera N, Dios Fuentes E, Blanco C, Alvaréz-Escolá C, Martín T, Webb SM, Bernabéu I, Villabona C, Soto-Moreno A, Gaztambide S, Díez JJ
Affiliated Institution / ERN:
Condition / Disease: Craniopharyngioma
Publication: Neuroendocrinology v111.10 p925-936 Year: 2021 ORPHAcode / other: ORPHA54595
DOI: 10.1159/000512161 Keywords: Craniopharyngioma,Diabetes insipidus,Elderly,Hypopituitarism,Neurosurgery,Therapeutic outcome,Visual field defects
MTG6

Thyroid Dysfunction and Thyroid Cancer in Childhood Cancer Survivors: Prevalence, Surveillance and Management


Author(s): Lebbink C, Waguespack S, van Santen H
Affiliated Institution / ERN: University Medical Center Utrecht ;
Condition / Disease: Thyroid carcinoma
Publication: Frontiers of Hormone Research p140-153 Year: 2021 ORPHAcode / other: ORPHA100088
DOI: 10.1159/000513805 Keywords:
MTG8

The Efficacy and Short- and Long-Term Side Effects of Radioactive Iodine Treatment in Pediatric Graves’ Disease: A Systematic Review


Author(s): Lutterman SL, Zwaveling-Soonawala N, Verberne HJ, Verburg FA, van Trotsenburg AP, Mooij CF
Affiliated Institution / ERN: Amsterdam UMC ; Erasmus MC: University Medical Center Rotterdam ;
Condition / Disease: Paediatric-onset Graves disease
Publication: European Thyroid Journal v10.5 p353-363 Year: 2021 ORPHAcode / other: ORPHA525731
DOI: 10.1159/000517174 Keywords: Graves' disease,Pediatric Graves' disease,Radioactive iodine,Side effects
MTG8

Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro‐osteogenic paracrine response: TERCELOI clinical trial


Author(s): Infante A, Gener B, Vázquez M, Olivares N, Arrieta A, Grau G, Llano I, Madero L, Bueno AM, Sagastizabal B, Gerovska D, Araúzo‐Bravo MJ, Astigarraga I, Rodríguez CI
Affiliated Institution / ERN: ERN BOND ;
Condition / Disease: Osteogenesis imperfecta
Publication: Clinical and Translational Medicine v11.1 Year: 2021 ORPHAcode / other: ORPHA666
DOI: 10.1002/ctm2.265 Keywords: cell therapy,mesenchymal stem cell,paracrine mechanism of action,regenerative medicine

Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience


Author(s): Scandurra C, Modica R, Maldonato NM, Dolce P, Dipietrangelo GG, Centello R, Di Vito V, Bottiglieri F, de Cicco F, Giannetta E, Isidori AM, Lenzi A, Muzii B, Faggiano A, Colao A
Affiliated Institution / ERN: AOU Federico II - Naples ; ERN BOND ;
Condition / Disease: Neuroendocrine Neoplasm
Publication: The Journal of Clinical Endocrinology & Metabolism v106.1 pe316-e327 Year: 2021 ORPHAcode / other: ORPHA877
DOI: 10.1210/clinem/dgaa760 Keywords: heterogeneity,metastases,neuroendocrine tumor,quality of life,resilience,severity

Surgical Practice in Girls with Congenital Adrenal Hyperplasia: An International Registry Study


Author(s): Hebenstreit D, Ahmed SF, Krone N, Krall C, Bryce J, Alvi S, Ortolano R, Lima M, Birkebaek N, Bonfig W, Claahsen van der Grinten H, Costa EC, Poyrazoglu S, de Vries L, Flück CE, Guran T, Bugrul F, Güven A, Iotova V, Koehler B, Schröder J, Konrad D, Gevers E, Krone R, Milenkovic T, Vieites A, Ross R, Tadokoro Cuccaro R, Hughes I, Acerini C, Springer A
Affiliated Institution / ERN: Copenhagen University Hospital, Rigshospitalet ; Sestre milosrdnice University Hospital Center ; AO City of Health and Science - Turin ; Assistance Publique-Hôpitaux de Marseille ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: Sexual Development v15.4 p229-235 Year: 2021 ORPHAcode / other: ORPHA418
DOI: 10.1159/000517055 Keywords: Congenital adrenal hyperplasia,Disorders of sexual development,Intersex,Surgery
MTG7

Impaired neuropsychological functioning in patients with hypopituitarism


Author(s): Slagboom TNA, Deijen JB, Van Bunderen CC, Knoop HA, Drent ML
Affiliated Institution / ERN: Amsterdam UMC ;
Condition / Disease: Hypopituitarism
Publication: Endocrinology, Diabetes & Metabolism v4.1 Year: 2021 ORPHAcode / other: ORPHA95502; ORPHA95488;
DOI: 10.1002/edm2.165 Keywords: cognition,executive function,hypopituitarism,information processing,memory,neuropsychology,pituitary
MTG6

A novel peptide antagonist of the human growth hormone receptor


Author(s): Basu R, Nahar K, Kulkarni P, Kerekes O, Sattler M, Hall Z, Neggers S, Holub JM, Kopchick JJ
Affiliated Institution / ERN: Erasmus MC: University Medical Center Rotterdam ;
Condition / Disease:
Publication: Journal of Biological Chemistry v296 p100588 Year: 2021 ORPHAcode / other:
DOI: 10.1016/j.jbc.2021.100588 Keywords: GH receptor,growth hormone,peptide antagonist,peptide mimetic,site 1-binding helix
Page 22 of 30« First«...10...2021222324...30...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2025. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance